Cargando…

Liver Cancer–Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma

Liver cancer–secreted serine protease inhibitor Kazal (LC-SPIK) is a protein that is specifically elevated in cases of hepatocellular carcinoma (HCC). We assessed the performance of LC-SPIK in detecting HCC, including its early stages, in patients with cirrhosis, hepatitis B virus (HBV), and hepatit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Felix, Shah, Pir Ahmad, Rao, Abhishek, Gifford-Hollingsworth, Cynthia, Chen, Anne, Trey, Gary, Soryal, Mina, Talat, Arslan, Aslam, Aysha, Nasir, Bilal, Choudhry, Saad, Ishtiaq, Rizwan, Sanoff, Hanna, Conteh, Lanla F., Noonan, Anne, Hu, Ke-Qin, Schmidt, Carl, Fu, Min, Civan, Jesse, Xiao, Gary, Lau, Daryl T.-Y., Lu, Xuanyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685967/ https://www.ncbi.nlm.nih.gov/pubmed/33512798 http://dx.doi.org/10.14309/ctg.0000000000000271

Ejemplares similares

Kazal-type serine proteinase inhibitors in the midgut of Phlebotomus papatasi
por: Sigle, Leah Theresa, et al.
Publicado: (2013)

Generation and Analysis of Serine Protease Inhibitor Kazal Type 3-Cre Driver Mice
por: Sakata, Kazuya, et al.
Publicado: (2014)

Regulation of serine protease inhibitor Kazal type-5 (SPINK5) gene expression in the keratinocytes
por: Le, Ngoc Anh, et al.
Publicado: (2014)

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers
por: Mehner, Christine, et al.
Publicado: (2015)

Serine protease inhibitor kazal-type 6 inhibits tumorigenesis of human hepatocellular carcinoma cells via its extracellular action
por: Ge, Kuikui, et al.
Publicado: (2016)

Genetic polymorphisms in serine protease inhibitor Kazal-type 5 and risk of atopic dermatitis: A meta-analysis
por: Li, Yunling, et al.
Publicado: (2020)

A Kazal-Type Serine Protease Inhibitor from the Defense Gland Secretion of the Subterranean Termite Coptotermes formosanus Shiraki
por: Negulescu, Horia, et al.
Publicado: (2015)

Management of chronic hepatitis B during pregnancy
por: Aslam, Aysha, et al.
Publicado: (2018)

Molecular Cloning and Functional Studies of Two Kazal-Type Serine Protease Inhibitors Specifically Expressed by Nasonia vitripennis Venom Apparatus
por: Qian, Cen, et al.
Publicado: (2015)

A two disulfide bridge Kazal domain from Phytophthora exhibits stable inhibitory activity against serine proteases of the subtilisin family
por: Tian, Miaoying, et al.
Publicado: (2005)

Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases
por: Zhu, Chengliang, et al.
Publicado: (2019)

Identification of Kazal Inhibitor Scaffolds with Identical Canonical Binding Loops and Their Effects on Binding Properties
por: Nagel, Felix, et al.
Publicado: (2023)

Structural Basis for Dual-Inhibition Mechanism of a Non-Classical Kazal-Type Serine Protease Inhibitor from Horseshoe Crab in Complex with Subtilisin
por: Shenoy, Rajesh T., et al.
Publicado: (2011)

High Prevalence of Serine Protease Inhibitor Kazal Type 1 Gene Variations Detected by Whole Gene Sequencing in Patients with Fibrocalculous Pancreatic Diabetes
por: Kolly, Anish, et al.
Publicado: (2017)

A Hypothesized Mechanism for Chronic Pancreatitis Caused by the N34S Mutation of Serine Protease Inhibitor Kazal-Type 1 Based on Conformational Studies
por: Kulke, Martin, et al.
Publicado: (2021)

Tazarotene-Induced Gene 1 (TIG1) Interacts with Serine Protease Inhibitor Kazal-Type 2 (SPINK2) to Inhibit Cellular Invasion of Testicular Carcinoma Cells
por: Shyu, Rong-Yaun, et al.
Publicado: (2019)

Women receive more inpatient resections and ablations for hepatocellular carcinoma than men
por: Sobotka, Lindsay, et al.
Publicado: (2017)

MAPK inhibitors induce serine peptidase inhibitor Kazal type 1 (SPINK1) secretion in BRAF V600E‐mutant colorectal adenocarcinoma
por: Räsänen, Kati, et al.
Publicado: (2017)

The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

The impact of physiological stress conditions on protein structure and trypsin inhibition of serine protease inhibitor Kazal type 1 (SPINK1) and its N34S variant
por: Buchholz, Ina, et al.
Publicado: (2020)

Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease
por: Caviglia, Gian Paolo, et al.
Publicado: (2022)

Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma
por: Jia, Jianlong, et al.
Publicado: (2022)

African Americans are less likely to receive curative treatment for hepatocellular carcinoma
por: Sobotka, Lindsay A, et al.
Publicado: (2018)

Geographical differences exist in high‐value care delivery for inpatient management of cirrhosis: Cost conscious care in cirrhosis
por: Sobotka, Lindsay A, et al.
Publicado: (2018)

Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
por: Akateh, Clifford, et al.
Publicado: (2019)

The Prevalence of Cationic Trypsinogen (PRSS1) and Serine Protease Inhibitor, Kazal Type 1 (SPINK1) Gene Mutations in Polish Patients with Alcoholic and Idiopathic Chronic Pancreatitis
por: Gasiorowska, Anita, et al.
Publicado: (2010)

Serine Protease Inhibitor Kazal Type 1 (SPINK1) c.194+2T > C Mutation May Predict Long-term Outcome of Endoscopic Treatments in Idiopathic Chronic Pancreatitis
por: Sun, Chang, et al.
Publicado: (2015)

A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
por: Hanif, Hira, et al.
Publicado: (2020)

Purification and Characterization of a Novel Kazal-Type Trypsin Inhibitor from the Leech of Hirudinaria manillensis
por: Lai, Yanmei, et al.
Publicado: (2016)

Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine
por: Chen, Yi-Ting, et al.
Publicado: (2022)

An update on the management of chronic hepatitis D
por: Shah, Pir Ahmad, et al.
Publicado: (2019)

A challenging case of alpha-fetoprotein-result discrepancies in a patient with chronic hepatitis B
por: Shah, Pir A, et al.
Publicado: (2020)

Ectopic Expression of a Neospora caninum Kazal Type Inhibitor Triggers Developmental Defects in Toxoplasma and Plasmodium
por: Tampaki, Zoi, et al.
Publicado: (2015)

Novel Kazal-type proteinase inhibitors from the skin secretion of the Splendid leaf frog, Cruziohyla calcarifer
por: Proaño-Bolaños, Carolina, et al.
Publicado: (2017)

Identification and Characterization of ShSPI, a Kazal-Type Elastase Inhibitor from the Venom of Scolopendra Hainanum
por: Luan, Ning, et al.
Publicado: (2019)

Increased Mosquito Midgut Infection by Dengue Virus Recruitment of Plasmin Is Blocked by an Endogenous Kazal-type Inhibitor
por: Ramesh, Karthik, et al.
Publicado: (2019)

Analysis of the inhibiting activity of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) on matrix metalloproteinases
por: Mendes, Soraia R., et al.
Publicado: (2020)

Kallikrein 5 Inhibition by the Lympho-Epithelial Kazal-Type Related Inhibitor Hinders Matriptase-Dependent Carcinogenesis
por: da Silva, Elaine Zayas Marcelino, et al.
Publicado: (2021)

Correction: Ectopic Expression of a Neospora caninum Kazal Type Inhibitor Triggers Developmental Defects in Toxoplasma and Plasmodium
Publicado: (2015)

A review of the impact of obesity on common gastrointestinal malignancies
por: Krishna, Somashekar G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3mueaq4t5s81lsqr56lt2rmqu1